Quantitative immunoblotting with fusion proteins.

M M Mitchell1, L D Loomis-Price

  • 1Henry M. Jackson Foundation, Rockville, MD.

Summary

Developing effective human immunodeficiency virus type 1 (HIV-1) vaccines requires precise measurement of immune responses. Immunoblotting techniques using fusion proteins help distinguish vaccine-induced immunity from infection-related responses.

Related Concept Videos